Sana Biotechnology

Emerging

Sana Biotechnology develops engineered cell and gene therapies with fusogen delivery technology to treat serious diseases through in vivo and ex vivo approaches.

Brand Intelligence Graph

Capabilities
Gene Therapy

Company Overview

Sana Biotechnology is a publicly traded gene therapy company founded in 2018 by veterans of Juno Therapeutics and other leading cell therapy companies. The company is building technologies to repair or replace any gene in any cell, with a particular focus on its proprietary fusogen-based delivery platform that enables engineered cells to fuse with and deliver genetic material to specific target cells in the body. This approach could enable off-the-shelf cell therapies and in vivo gene editing without the need to harvest and engineer patient cells individually. Sana has programs targeting blood cancers, autoimmune diseases, and type 1 diabetes, exploring both in vivo gene delivery and ex vivo engineered cell therapies. The company went public through an IPO in 2021, raising substantial capital to advance its novel platform. Sana has formed research collaborations with academic institutions and pharmaceutical companies to advance specific programs. The company represents the cutting edge of cell and gene therapy with proprietary delivery technologies that could unlock new therapeutic approaches beyond what current viral vector and CRISPR systems enable.

Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Sana Biotechnology is an emerging player bringing innovative solutions to the Biotechnology market.

Frequently Asked Questions

Not So Random Others

Amazon

Consumer Retail
B2cMarketplaceRetailtechTechnologyCloud NativeGlobalPublicFortune500

Amazon was founded in 1994 by Jeff Bezos in Bellevue, Washington as an online bookstore operating from a garage, with the stated ambition of becoming "the everything store" — a long-term vision that p

IBM

Enterprise Software
B2bEnterprisePlatformSaasPublic

International Business Machines Corporation (IBM) is an Armonk, New York-based global technology and consulting company — publicly traded on the New York Stock Exchange (NYSE: IBM) as an S&P 500 compo

Shopify

E-commerce
B2b2cMarketplacePlatformRetailtechSaasPublicB2b

Shopify Inc. is an Ottawa, Canada-based e-commerce platform — listed on NYSE (NYSE: SHOP) — providing 4.82+ million active merchant stores of all sizes (from solo entrepreneurs to enterprise brands) w

CrowdStrike

Security
B2bCybersecuritySaasSecurityPublic

CrowdStrike is an AI-native cybersecurity company founded in 2011 by George Kurtz, Dmitri Alperovitch, and Gregg Marston and headquartered in Austin, Texas, that built the endpoint detection and respo

Palo Alto Networks

Security
B2bCybersecurityEnterpriseSaasSecurityPublic

Palo Alto Networks, Inc. is a Santa Clara, California-based cybersecurity platform company — publicly traded on the NASDAQ (NASDAQ: PANW) as an S&P 500 Information Technology component — providing net

NetSuite

Finance
B2bSaasAi PoweredFintechAutomationEnterprise

NetSuite is a San Mateo, California and Austin, Texas-based cloud enterprise resource planning (ERP) platform and business unit of Oracle Corporation (NYSE: ORCL) — serving over 40,000 customers in 21

For Sana Biotechnology

Claim This Profile

Are you from Sana Biotechnology? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Sana Biotechnology Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Sana Biotechnology vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →